{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:09:47Z","timestamp":1791245387180,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2019. Other selected articles can be found online at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.biomedcentral.com\/collections\/annualupdate2019\">https:\/\/www.biomedcentral.com\/collections\/annualupdate2019<\/jats:ext-link>. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.springer.com\/series\/8901\">http:\/\/www.springer.com\/series\/8901<\/jats:ext-link>.<\/jats:p>","DOI":"10.1186\/s13054-019-2371-3","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T02:02:27Z","timestamp":1552096947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia"],"prefix":"10.1186","volume":"23","author":[{"given":"Catia","family":"Cill\u00f3niz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Domined\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"issue":"Suppl 2","key":"2371_CR1","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27\u201372.","journal-title":"Clin Infect Dis"},{"key":"2371_CR2","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/thoraxjnl-2013-203384","volume":"68","author":"S Aliberti","year":"2013","unstructured":"Aliberti S, Cilloniz C, Chalmers JD, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013;68:997\u20139.","journal-title":"Thorax."},{"key":"2371_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/thx.2010.143982","volume":"66","author":"C Cill\u00f3niz","year":"2011","unstructured":"Cill\u00f3niz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66:340\u20136.","journal-title":"Thorax."},{"key":"2371_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"2371_CR5","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","volume":"6","author":"A Versporten","year":"2018","unstructured":"Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6:e619\u201329.","journal-title":"Lancet Glob Health"},{"key":"2371_CR6","unstructured":"European Antimicrobial Resistance Surveillance Network. Surveillance of antimicrobial resistance in Europe 2016. 2016. Available at: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AMR-surveillance-Europe-2016.pdf. Accessed 19 Nov 2018."},{"key":"2371_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/2049-632X.12033","volume":"67","author":"SL Gellatly","year":"2013","unstructured":"Gellatly SL, Hancock REW. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013;67:159\u201373.","journal-title":"Pathog Dis"},{"key":"2371_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2217\/fmb.15.100","volume":"10","author":"A Crousilles","year":"2015","unstructured":"Crousilles A, Maunders E, Bartlett S, et al. Which microbial factors really are important in Pseudomonas aeruginosa infections? Future Microbiol. 2015;10:1825\u201336.","journal-title":"Future Microbiol"},{"key":"2371_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1183\/09031936.00091809","volume":"35","author":"H von Baum","year":"2010","unstructured":"von Baum H, Welte T, Marre R, et al. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J. 2010;35:598\u2013605.","journal-title":"Eur Respir J"},{"key":"2371_CR10","doi-asserted-by":"publisher","first-page":"1709910","DOI":"10.1183\/13993003.01190-2017","volume":"52","author":"MI Restrepo","year":"2018","unstructured":"Restrepo MI, Babu BL, Reyes LF, et al. Burden and risk factors for pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018;52:1709910.","journal-title":"Eur Respir J"},{"key":"2371_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.chest.2016.03.042","volume":"150","author":"C Cill\u00f3niz","year":"2016","unstructured":"Cill\u00f3niz C, Gabarr\u00fas A, Ferrer M, et al. Community-acquired pneumonia due to multidrug and non-multidrug resistant Pseudomonas aeruginosa. Chest. 2016;150:415\u201325.","journal-title":"Chest."},{"key":"2371_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191721","volume":"13","author":"M Ferrer","year":"2018","unstructured":"Ferrer M, Travierso C, Cilloniz C, et al. Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS One. 2018;13:e0191721.","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"2371_CR13","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","volume":"64","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1\u201355.","journal-title":"Thorax"},{"key":"2371_CR14","doi-asserted-by":"publisher","unstructured":"Al-Jaghbeer MJ, Justo JA, Owens W, et al. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018. https:\/\/doi.org\/10.1007\/s15010-018-1147-z [Epub ahead of print].","DOI":"10.1007\/s15010-018-1147-z"},{"key":"2371_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/qjmed\/hcx148","volume":"110","author":"TJ John","year":"2017","unstructured":"John TJ, Lalla U, Taljaard JJ, et al. An outbreak of community-acquired pseudomonas aeruginosa pneumonia in a setting of high water stress. QJM. 2017;110:855\u20136.","journal-title":"QJM."},{"key":"2371_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/resp.12663","volume":"21","author":"C Cill\u00f3niz","year":"2016","unstructured":"Cill\u00f3niz C, Civljak R, Nicolini A, Torres A. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology. 2016;21:65\u201375.","journal-title":"Respirology."},{"key":"2371_CR17","unstructured":"WHO. High levels of antibiotic resistance found worldwide, new data shows. 2018. Available at: WHO. http:\/\/www.who.int\/mediacentre\/news\/releases\/2018\/antibiotic-resistance-found\/en\/. Accessed 25 Jun 2018."},{"key":"2371_CR18","doi-asserted-by":"publisher","first-page":"e802","DOI":"10.1016\/j.ijid.2013.03.021","volume":"17","author":"M Eveillard","year":"2013","unstructured":"Eveillard M, Kempf M, Belmonte O, et al. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis. 2013;17:e802\u20135.","journal-title":"Int J Infect Dis"},{"key":"2371_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","volume":"30","author":"D Wong","year":"2017","unstructured":"Wong D, Nielsen TB, Bonomo RA, et al. Clinical and pathophysiological overview of acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30:409\u201347.","journal-title":"Clin Microbiol Rev"},{"key":"2371_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1586\/14787210.2015.1025055","volume":"13","author":"C Dexter","year":"2015","unstructured":"Dexter C, Murray GL, Paulsen IT, Peleg AY. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti-Infect Ther. 2015;13:567\u201373.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2371_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/cid\/ciy194","volume":"67","author":"L Mody","year":"2018","unstructured":"Mody L, Foxman B, Bradley S, et al. Longitudinal assessment of multidrug-resistant organisms in newly admitted nursing facility patients: implications for an evolving population. Clin Infect Dis. 2018;67:837\u201344.","journal-title":"Clin Infect Dis"},{"key":"2371_CR22","doi-asserted-by":"publisher","first-page":"E491","DOI":"10.1111\/1469-0691.12017","volume":"18","author":"C Peng","year":"2012","unstructured":"Peng C, Zong Z, Fan H. Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China. Clin Microbiol Infect. 2012;18:E491\u20133.","journal-title":"Clin Microbiol Infect"},{"key":"2371_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3947\/ic.2017.49.4.297","volume":"49","author":"YW Son","year":"2017","unstructured":"Son YW, Jung IY, Ahn MY, et al. A case of community-acquired pneumonia caused by multidrug-resistant Acinetobacter baumannii in Korea. Infect Chemother. 2017;49:297\u2013300.","journal-title":"Infect Chemother"},{"key":"2371_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/j.1440-1843.2009.01630.x","volume":"14","author":"CWM Ong","year":"2009","unstructured":"Ong CWM, Lye DCB, Khoo KL, et al. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology. 2009;14:1200\u20135.","journal-title":"Respirology."},{"key":"2371_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3343\/alm.2018.38.3.266","volume":"38","author":"YA Kim","year":"2018","unstructured":"Kim YA, Kim JJ, Won DJ, Lee K. Seasonal and temperature-associated increase in community-onset Acinetobacter baumannii complex colonization or infection. Ann Lab Med. 2018;38:266\u201370.","journal-title":"Ann Lab Med"},{"key":"2371_CR26","doi-asserted-by":"crossref","first-page":"ofy044","DOI":"10.1093\/ofid\/ofy044","volume":"5","author":"DP Serota","year":"2018","unstructured":"Serota DP, Sexton ME, Kraft CS, Palacio F. Severe community-acquired pneumonia due to Acinetobacter baumannii in North America: case report and review of the literature. Open Forum Infect Dis. 2018;5:ofy044.","journal-title":"Open Forum Infect Dis"},{"key":"2371_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4161\/viru.25747","volume":"4","author":"EA Eugenin","year":"2013","unstructured":"Eugenin EA. Community-acquired pneumonia infections by Acinetobacter baumannii: how does alcohol impact the antimicrobial functions of macrophages? Virulence. 2013;4:435\u20136.","journal-title":"Virulence."},{"key":"2371_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fimmu.2018.00178","volume":"9","author":"G Kamoshida","year":"2018","unstructured":"Kamoshida G, Kikuchi-Ueda T, Nishida S, et al. Pathogenic bacterium Acinetobacter baumannii inhibits the formation of neutrophil extracellular traps by suppressing neutrophil adhesion. Front Immunol. 2018;9:178.","journal-title":"Front Immunol"},{"key":"2371_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1128\/JCM.40.2.685-686.2002","volume":"40","author":"NM Anstey","year":"2002","unstructured":"Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol. 2002;40:685\u20136.","journal-title":"J Clin Microbiol"},{"key":"2371_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.682","volume":"23","author":"AY Peleg","year":"2007","unstructured":"Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007;23:3\u201313.","journal-title":"Diabetes Metab Res Rev"},{"key":"2371_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fcimb.2017.00483","volume":"7","author":"CR Lee","year":"2017","unstructured":"Lee CR, Lee JH, Park KS, et al. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol. 2017;7:483.","journal-title":"Front Cell Infect Microbiol"},{"key":"2371_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1473-3099(17)30489-9","volume":"18","author":"D Gu","year":"2018","unstructured":"Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18:37\u201346.","journal-title":"Lancet Infect Dis"},{"key":"2371_CR33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/cmi.12466","volume":"17","author":"V Cano","year":"2015","unstructured":"Cano V, March C, Insua JL, et al. Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes. Cell Microbiol. 2015;17:1537\u201360.","journal-title":"Cell Microbiol"},{"key":"2371_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1099\/jmm.0.000788","volume":"67","author":"C Rafat","year":"2018","unstructured":"Rafat C, Messika J, Barnaud G, et al. Hypervirulent Klebsiella pneumoniae, a 5-year study in a French ICU. J Med Microbiol. 2018;67:1083\u20139.","journal-title":"J Med Microbiol"},{"key":"2371_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2334-12-3","volume":"12","author":"B Rammaert","year":"2012","unstructured":"Rammaert B, Goyet S, Beaut\u00e9 J, et al. Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment. BMC Infect Dis. 2012;12:3.","journal-title":"BMC Infect Dis"},{"key":"2371_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jiac.2016.09.002","volume":"23","author":"T Ishida","year":"2017","unstructured":"Ishida T, Ito A, Washio Y, et al. Risk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: evaluation of PES pathogens. J Infect Chemother. 2017;23:23\u20138.","journal-title":"J Infect Chemother"},{"key":"2371_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2334-10-307","volume":"10","author":"YT Lin","year":"2010","unstructured":"Lin YT, Jeng YY, Chen TL, Fung C-P. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis. 2010;10:307.","journal-title":"BMC Infect Dis"},{"key":"2371_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jmii.2012.06.001","volume":"46","author":"C-P Tseng","year":"2013","unstructured":"Tseng C-P, Wu H-S, Wu T-H, et al. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care. J Microbiol Immunol Infect. 2013;46:217\u201323.","journal-title":"J Microbiol Immunol Infect"},{"key":"2371_CR39","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1128\/JCM.00676-11","volume":"49","author":"D Decr\u00e9","year":"2011","unstructured":"Decr\u00e9 D, Verdet C, Emirian A, et al. Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol. 2011;49:3012\u20134.","journal-title":"J Clin Microbiol"},{"key":"2371_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/trstmh\/try022","volume":"112","author":"M Inghammar","year":"2018","unstructured":"Inghammar M, Borand L, Goyet S, et al. Community-acquired pneumonia and gram-negative bacilli in Cambodia-incidence, risk factors and clinical characteristics. Trans R Soc Trop Med Hyg. 2018;112:57\u201363.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2371_CR41","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1080\/10428194.2016.1193859","volume":"57","author":"TM Baker","year":"2016","unstructured":"Baker TM, Satlin MJ. The growing threat of multidrug-resistant gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma. 2016;57:2245\u201358.","journal-title":"Leuk Lymphoma"},{"key":"2371_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","volume":"25","author":"JS Brooke","year":"2012","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25:2\u201341.","journal-title":"Clin Microbiol Rev"},{"key":"2371_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3348\/kjr.2016.17.6.961","volume":"17","author":"YK Cha","year":"2016","unstructured":"Cha YK, Kim JS, Park SY, et al. Computed tomography findings of community-acquired Stenotrophomonas maltophilia pneumonia in an immunocompetent patient: a case report. Korean J Radiol. 2016;17:961\u20134.","journal-title":"Korean J Radiol"},{"key":"2371_CR44","first-page":"44","volume":"24","author":"M Geller","year":"2018","unstructured":"Geller M, Nunes CP, Oliveira L, Nigri R. S. maltophilia pneumonia: a case report. Respir Med Case Rep. 2018;24:44\u20135.","journal-title":"Respir Med Case Rep"},{"key":"2371_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00277-014-2028-x","volume":"93","author":"M Mori","year":"2014","unstructured":"Mori M, Tsunemine H, Imada K, et al. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Ann Hematol. 2014;93:901\u201311.","journal-title":"Ann Hematol"},{"key":"2371_CR46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10096-009-0709-5","volume":"28","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Kastoris AC, Vouloumanou EK, Dimopoulos G. Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur J Clin Microbiol Infect Dis. 2009;28:719\u201330.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2371_CR47","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1183\/13993003.01144-2016","volume":"48","author":"A Torres","year":"2016","unstructured":"Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016;48:1764\u201378.","journal-title":"Eur Respir J"},{"key":"2371_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MCP.0000000000000263","volume":"22","author":"O Sibila","year":"2016","unstructured":"Sibila O, Rodrigo-Troyano A, Shindo Y, et al. Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulm Med. 2016;22:219\u201326.","journal-title":"Curr Opin Pulm Med"},{"key":"2371_CR49","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1128\/AAC.02582-14","volume":"58","author":"AE Gross","year":"2014","unstructured":"Gross AE, Van Schooneveld TC, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014;58:5262\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2371_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","volume":"12","author":"E Prina","year":"2015","unstructured":"Prina E, Ranzani OT, Polverino E, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thorac Soc. 2015;12:153\u201360.","journal-title":"Ann Am Thorac Soc"},{"key":"2371_CR51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","volume":"188","author":"Y Shindo","year":"2013","unstructured":"Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188:985\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"2371_CR52","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/crj.12674","volume":"12","author":"B Cao","year":"2018","unstructured":"Cao B, Huang Y, She DY, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese thoracic society, Chinese Medical Association. Clin Respir J. 2018;12:1320\u201360.","journal-title":"Clin Respir J"},{"key":"2371_CR53","volume-title":"Australian Clinical Practice Guidelines","author":"National Health and Medical Research Council","year":"2014","unstructured":"National Health and Medical Research Council. Therapeutic guidelines antibiotic version 15. In: Australian Clinical Practice Guidelines. Canberra: National Health and Medical Research Council; 2014."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2371-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-019-2371-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2371-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:15:24Z","timestamp":1728922524000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2371-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["2371"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2371-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,9]]},"assertion":[{"value":"9 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"79"}}